Abstract:Ca2+ antagonist drugs are widely used in therapy of cardiovascular disorders. Three chemical classes of drugs bind to three separate, but allosterically interacting, receptor sites on CaV1.2 channels, the most prominent voltage-gated Ca2+ (CaV) channel type in myocytes in cardiac and vascular smooth muscle. The 1,4-dihydropyridines are used primarily for treatment of hypertension and angina pectoris and are thought to act as allosteric modulators of voltage-dependent Ca2+ channel activation, whereas phenylalkylamines and benzothiazepines are used primarily for treatment of cardiac arrhythmias and are thought to physically block the pore. The structural basis for the different binding, action, and therapeutic uses of these drugs remains unknown. Here we present crystallographic and functional analyses of drug binding to the bacterial homotetrameric model CaV channel CaVAb, which is inhibited by dihydropyridines and phenylalkylamines with nanomolar affinity in a state-dependent manner. The binding site for amlodipine and other dihydropyridines is located on the external, lipid-facing surface of the pore module, positioned at the interface of two subunits. Dihydropyridine binding allosterically induces an asymmetric conformation of the selectivity filter, in which partially dehydrated Ca2+ interacts directly with one subunit and blocks the pore. In contrast, the phenylalkylamine Br-verapamil binds in the central cavity of the pore on the intracellular side of the selectivity filter, physically blocking the ion-conducting pathway. Structure-based mutations of key amino-acid residues confirm drug binding at both sites. Our results define the structural basis for binding of dihydropyridines and phenylalkylamines at their distinct receptor sites on CaV channels and offer key insights into their fundamental mechanisms of action and differential therapeutic uses in cardiovascular diseases.

[Analysis of the Divalent Cation Blocking in Ion Channels by Crystal Structure and Molecular Dynamics Simulations]

The structural basis of divalent cation block in a tetrameric prokaryotic sodium channel

The crystal structure of a voltage-gated sodium channel

The hitchhiker’s guide to the voltage-gated sodium channel galaxy

Molecular Basis for Pore Blockade of Human Na+ Channel Nav1.2 by the Μ-Conotoxin KIIIA.

Computational Modeling Of Sodium Channel Inactivation

Blocker studies of the functional architecture of the NMDA receptor channel

Voltage sensors of a Na+ channel dissociate from the pore domain and form inter-channel dimers in the resting state

Ionic Coulomb blockade and anomalous mole fraction effect in NaChBac bacterial ion channels

Lysine and the Na+/K+ Selectivity in Mammalian Voltage-Gated Sodium Channels.

Analysis of the Selectivity Filter of the Voltage-Gated Sodium Channel NavRh

Effect of Trivalent “Calcium-Like” Cations on Ionic Transport Behaviors of Artificial Calcium-Responsive Nanochannels

DIVALENT CATION MODULATION OF A-TYPE POTASSIUM CHANNELS IN ACUTELY DISSOCIATED CENTRAL NEURONS FROM WIDE-TYPE AND MUTANT DROSOPHILA

Simulation Studies of Ion Permeation and Selectivity in Voltage-Gated Sodium Channels

Deciphering Ca2+ Permeation and Valence Selectivity in Cav1: Molecular Dynamics Simulations Reveal the Three-Ion Knock-on Mechanism

Structural basis for pore blockade of the human cardiac sodium channel Nav1.5 by tetrodotoxin and quinidine

Structural Basis for Ion Selectivity Revealed by High-Resolution Crystal Structure of Mg 2+ Channel MgtE

Structural implications of weak Ca2+ block in Drosophila cyclic nucleotide-gated channels

Structural Investigation of a Bacterial Voltage-Gated Sodium Channel NaVRh

Atomistic modeling and molecular dynamics analysis of human CaV1.2 channel using external electric field and ion pulling simulations

Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs